SFA
AMED

Semmax Financial Advisors’s Amedisys AMED Stock Holding History

Semmax Financial Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$26K – 254
2021
Q1 		$26K Buy
+100
New +$28.2K 0.01% 156

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Semmax Financial Advisors's AMED Position: Q2 2021 in Review

Semmax Financial Advisors sold out of Amedisys (AMED) in Q2 2021, closing a stake of 100 shares — an estimated $26K sold.

Semmax Financial Advisors first reported a position in AMED in Q1 2021 and held it in 1 quarter. The position peaked at $26K in Q1 2021. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Semmax Financial Advisors reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Semmax Financial Advisors sold 100 Amedisys shares in Q2 2021, an estimated $26K.
  • Semmax Financial Advisors first reported a position in Amedisys in Q1 2021 and held it in 1 quarter.
  • Semmax Financial Advisors's Amedisys position peaked at $26K in Q1 2021.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Semmax Financial Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.